• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • COVID-19
  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • Artificial Intelligence
    • Blockchain
    • Mobile Health
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

75% of Healthcare Organizations Have Not Yet Begun ICD-10 Testing

by Fred Pennic 07/31/2013 4 Comments

75% of healthcare organizations have not yet begun ICD-10 testing, but also expect testing to take between 11-16 months, according to recent survey by QualiTest. Conducted during June 2013, the survey included over 300 senior level IT, revenue management, and medical coding professionals that have described themselves as “directly involved with ICD-10 remediation efforts.”

The majority of respondents have either completed their ICD-10 assessment or are currently in the process of running it.  The findings indicated they were comfortable with their testing abilities to verify their technology stack and their internal coder readiness but indicated concern with the ability of testing to cover functional integration with key trade partners and revenue impact testing.

75% of Healthcare Organizations Have Not Yet Begun ICD-10 Testing
Source: Qualitestgroup

Other key findings include:

  • 61% of healthcare organizations are planning thorough revenue impact testing with our trading partners for the ICD-10 transition.
  • Those planning to use GEMs or cross-walks for generating test data were most worried about incorrect mapping or the high cost of such tools (combined, about 80% of respondents).
  • 38% say their healthcare organization is focused on ICD-10 testing more than on clinical documentation improvements (CDI)
  • Most organization are either planning to code their own data, or do not know how they will source the data they will use in their database (with the third most popular item being acquiring a tailored database).
  • Half the organizations are planning on coding their own data, but know that the main problem with this is incorrect coding and the availability of the coded test data, which both would delay the testing effort.
  • 85% planning dual coding in both ICD-9 and ICD-10 before October 2014.
  • Concerning acquiring a tailored database of dual-coded medical records, 44% feared the additional costs of attaining such a system (though they recognized the benefit of doing so), with 32% concerned with the accuracy of the in-house coders who will be using the system.
  • 33% of respondents are planning to test with up to 5 payers

For the complete survey results, click here

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Most Popular

Survey: Clinician Burnout Is A Public Health Crisis Demanding Urgent Action

17 Execs Share How Health IT Can Address Clinician Burnout, Staffing, & Capacity

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Q/A: Dr. Johnson Talks Racial Disparities in Breast Cancer Care

Northwell Health Extends Contract with Allscripts Sunrise Platform Through 2027

Northwell to Deploy Epic Enterprise EHR Platform Across System

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Sanofi Cuts Price of Lantus Insulin by 78% & Caps Out of Pocket Costs at $35 for All Patients

Pfizer Acquires Seagen for $43B to Tackle Cancer

Pfizer Acquires Seagen for $43B to Tackle Cancer

5 Key Trends Driving Purchasing Decisions in Healthcare IT

5 Key Trends Driving Purchasing Decisions in Healthcare IT

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Sanofi to Acquire Diabetes Therapy Maker Provention Bio for $2.9B

Dr. Arti Masturzo

Q/A: Dr. Masturzo Talks Addressing Food Insecurity with Patients

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Transcarent Acquires 98point6 AI-Powered Virtual Care Platform and Care Business

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Eli Lilly Cuts Insulin Prices by 70%, Caps Patient Costs at $35 Per Month

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • 2023 Editorial Calendar
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2023. HIT Consultant Media. All Rights Reserved. Privacy Policy |